MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
125 hedge funds and large institutions have $1.58B invested in Mirati Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 49 increasing their positions, 30 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
125
Holders Change
+17
Holders Change %
+15.74%
% of All Funds
2.86%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.14%
New
31
Increased
49
Reduced
30
Closed
14
Calls
$33.1M
Puts
$34.8M
Net Calls
-$1.66M
Net Calls Change
-$10.9M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$20.1M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$20M |
| 3 |
Jennison Associates
New York
|
+$18.1M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$17.1M |
| 5 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
+$13.8M |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$35.2M |
| 2 |
BC
Broadfin Capital
New York
|
-$31.2M |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$22.7M |
| 4 |
DM
Deerfield Management
New York
|
-$21.6M |
| 5 |
D.E. Shaw & Co
New York
|
-$6.86M |
